Results 71 to 80 of about 4,200 (201)

Aliskiren ยาใหม่ในกลุ่ม Renin Inhibitors

, 2008
Aliskirenเป็นยาตัวแรกในกลุ่ม renin inhibitors ที่ได้รับการรับรองจากคณะกรรมการอาหารและยาประเทศสหรัฐอเมริกา เดือนมีนาคม ปี พ.ศ. 2550 ใช้สำหรับรักษาโรคความดันโลหิตสูงระดับอ่อนถึงปานกลาง โดยอาจใช้แบบเดี่ยว หรือใช้ร่วมกับยาลดความดันโลหิตสูงกลุ่มอื่น ๆ ...
ชนะกิจ, ธีราพร
core  

Aliskiren increased turnover of triglyceride.

, 2013
The transcript expression of sterol regulatory element binding protein-1 (SREBP1), carbohydrate responsive element binding protein (ChREBP), peroxisome proliferator-activated receptor gamma (PPAR-γ), fatty acid transport protein 1 and 4 (FATP1, FATP4 ...
Kuei-Chuan Lee (383486), Yun-Cheng Hsieh (474597), Yi-Hsiang Huang (115190), Che-Chang Chan (115183), Han-Chieh Lin (115193), Ying-Ying Yang (474596)   +5 more
core   +1 more source

Effect of aliskiren on blood pressure and plasma angiotensin II levels.

, 2013
Data was obtained after 12-inducing diets and aliskiren. A. Heart weight to body weight ratios; B. Angiotensin II levels; C. Systolic blood pressure; and D. Diastolic blood pressure.
Jian Guan (288307), Gaurav Alreja (495784), Nicole Metes-Kosik (495785), Jacob Joseph (495786), Hui Zhi (106532), Ivan Luptak (495783), Jianru Shi (288305)   +6 more
core   +1 more source

Aliskiren – an antihypertensive renin inhibitor in the treatment of patients with chronic kidney disease [PDF]

, 2017
Introduction. The renin-angiotensin-aldosterone system (RAAS) plays an important role in the pathogenesis of hypertension, cardiovascular diseases (CVDs) and chronic kidney disease (CKD).
Łukawski, Krzysztof, Iwona Baranowicz-Gąszczyk, Krzysztof Łukawski, Baranowicz-Gąszczyk, Iwona   +3 more
core   +1 more source

Haemodynamic effects of aliskiren in decompensated severe heart failure

, 2012
Aim: The renin-angiotensin-aldosterone system (RAAS) has dual pathways to angiotensin II production; therefore, multiple blockages may be useful in heart failure.
Cardoso, Juliano N., Vieira, Kelly R., Puig, Raphael N., Ochiai, Marcelo E., Brancalhao, Euler O., Lima, Marcelo V., Barretto, Antonio P.   +6 more
core   +2 more sources

Effects of aliskiren- and ramipril-based treatment on central aortic blood pressure in elderly with systolic hypertension: a substudy of AGELESS

Vascular Health and Risk Management, 2014
Fabio Baschiera,1 William Chang,2 Patrick Brunel1 On behalf of the AGELESS Study Group 1Novartis Pharma AG, Basel, Switzerland; 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA Background: Systolic hypertension is the most common form of ...
Baschiera F, Chang W, Brunel P
doaj  

Aliskiren – an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension

, 2008
Kristina AllikmetsDepartment of Drug Development and Medical Affairs, Nycomed Group, Roskilde, DenmarkAbstract: The importance of renin-angiotensin-aldosterone system (RAAS) in diseases such as hypertension, congestive heart failure and chronic renal ...
Kristina Allikmets
core  

A Total synthesis of aliskiren starting from D-Tartrate diester

, 2017
Aliskiren; D-Tartrate diester; Symmetric precursor; Total ...
고수영
core   +1 more source

Cardioprotection by aliskiren

, 2015
© 2015 Dr. Suang Suang KoidIschemic heart disease is one of the largest causes of death and disability in the world. The leading treatments for this condition are ACE inhibitors and angiotensin receptor blockers (ARBs), which in addition to reducing ...
KOID, SUANG SUANG
core   +1 more source

Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect

Frontiers in Neurology, 2019
Epidemiological studies suggest that pharmacological reduction of systemic hypertension lowers incidence and severity of stroke. However, whether the reduction of blood pressure per se or the compounds used to reduce hypertension are responsible for this
Hamdollah Panahpour, Hamdollah Panahpour, Nicole A. Terpolilli, Nicole A. Terpolilli, Nicole A. Terpolilli, David Schaffert, Carsten Culmsee, Nikolaus Plesnila, Nikolaus Plesnila   +8 more
doaj   +1 more source